VNDA AS OF 06/30/2014

Company

Vanda Pharmaceuticals Inc.

Filed

July 10, 2014

Accession Number

0000080255-14-000609

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →